Cargando…
A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
Drug repositioning is a new way of applying the existing therapeutics to new disease indications. Due to the exorbitant cost and high failure rate in developing new drugs, the continued use of existing drugs for treatment, especially anti-tumor drugs, has become a widespread practice. With the assis...
Autores principales: | He, Binsheng, Hou, Fangxing, Ren, Changjing, Bing, Pingping, Xiao, Xiangzuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340770/ https://www.ncbi.nlm.nih.gov/pubmed/34367996 http://dx.doi.org/10.3389/fonc.2021.711225 |
Ejemplares similares
-
Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021) -
In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021) -
A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
por: Nehdi, Atef, et al.
Publicado: (2021) -
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019) -
An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)